InvestorsHub Logo
Followers 6
Posts 166
Boards Moderated 0
Alias Born 07/03/2021

Re: Giovanni post# 32707

Tuesday, 08/16/2022 10:19:05 AM

Tuesday, August 16, 2022 10:19:05 AM

Post# of 36588
A little help with this news release...does it mean that they need to continue the study to gather additional data points?

Just a little confused by "the Company will now amend the Study protocol with the proposed new primary efficacy endpoints and submit to the FDA for further discussion and agreement."

Thanks for any clarification from the smart folks out there.